Weight loss drugs like Mounjaro and Ozempic have become so widespread that analysts estimate the industry could be worth $144 billion by 2030. With one in eight people worldwide living with obesity, there’s growing hope these medications could transform lives. But concerns are rising that we’re entering a new era of “thinness” — fuelled by a surge in people, including celebrities, using them for cosmetic purposes, despite the drugs not being intended for those with a healthy BMI. Experts warn of health risks, misconceptions, and the rapid spread of misinformation on social media. Neelam Tailor speaks to Dr Jack Mosley and Dr Courtney Younglove to ask: are we in the midst of a global “human experiment”? From side effects and mental health to beauty standards, muscle loss, and who’s being left behind, we examine the real impact of these drugs. Watch the full video on It’s Complicated — a new Guardian YouTube channel exploring the hows and whys behind the stories that matter. Link in bio 🔗